 |
Name |
Generic Name |
|
|
Cardiovascular |
|
Aggrastat® |
tirofiban hydrochloride |
- unstable angina
- non-Q-wave myocardial infarction
|
|
Cozaar® |
losartan potassium |
|
|
Hyzaar® |
losartan potassium and hydrochlorothiazide |
|
|
Zocor® |
simvastatin |
- elevated cholesterol
- associated total/coronary mortality1
- raise HDL cholesterol
- reduce triglycerides
- reduce stroke risk1
|
|
|
ezetimibe, Schering-Ploughs
investigational cholesterol absorption inhibitor, with Zocor2,3 |
- lower elevated cholesterol
|
|
Endocrinology |
|
Fosamax® |
alendronate sodium |
- treatment and prevention of postmenopausal osteoporosis
- reduced osteoporotic fracture risk
- treatment of male osteoporosis to increase bone mass
- treatment of glucocorticoid-induced osteoporosis
- Pagets disease of the bone
|
|
Propecia® |
finasteride |
- treatment of male pattern hair loss
|
|
Proscar® |
finasteride |
- treatment of symptomatic benign prostate enlargement
|
|
Gastrointestinal |
|
Pepcid AC®4 |
famotidine |
|
|
Infection |
|
Cancidas® |
caspofungin acetate |
- treatment of invasive aspergillosis in patients who did not respond to or were intolerant of other antifungal therapies
|
|
Crixivan® |
indinavir sulfate |
|
|
Stocrin®5 |
efavirenz |
|
|
Invanz®6 |
ertapenem sodium |
- initial empiric treatment of community-acquired and mixed infections, such as intra-abdominal infections
|
|
Inflammation |
|
Vioxx® |
rofecoxib |
- osteoarthritis
- acute pain
|
|
MK-6633 |
etoricoxib |
- osteoarthritis
- acute pain
- rheumatoid arthritis
|
|
Neurological |
|
Maxalt® |
rizatriptan benzoate |
|
|
MK-8693 |
|
- emesis due to chemotherapy
|
|
Substance P
Antagonist3 |
|
|
|
Ophthalmic |
|
Cosopt® |
dorzolamide hydrochloride and timolol maleate |
- lower intraocular pressure
|
|
Trusopt® |
dorzolamide hydrochloride |
- lower intraocular pressure
|
|
Timoptic-XE® |
timolol maleate ophthalmic gel forming solution |
- lower intraocular pressure
|
|
Respiratory |
|
Singulair® |
montelukast sodium |
- chronic asthmaadults and in children as young as age 2
|
|
|
fixed-combination tablet2,3 containing Claritin® (loratadine) and Singulair |
|
|
Vaccines |
|
Comvax® |
Haemophilus b conjugate and hepatitis B (recombinant) vaccine |
- Haemophilus influenzae type b disease and hepatitis B disease
|
|
HIV/AIDS3 |
|
|
|
Herpes zoster3 |
|
- herpes zoster (shingles) in adults
|
|
Human papillomavirus3 |
|
- HPV infections and prevention of cervical cancer
|
|
Rotavirus3 |
|
|
|
Vaqta® |
inactivated hepatitis A vaccine |
|
|
Varivax® |
varicella virus vaccine live [Oka/Merck strain] |
|
|
* This list excludes a number of older Company products introduced before 1990
1 In patients with coronary heart disease and elevated cholesterol
2 Under development by Merck and Schering-Plough Corporation joint ventures
3 Products in development
4 Marketed by the Johnson & Johnson Merck Consumer Pharmaceuticals Co.
5 Efavirenz is marketed by DuPont Pharmaceuticals Company as Sustiva in the U.S.,
Canada and certain European countries and by Merck in the rest of the world as Stocrin
6 Products under U.S. Food and Drug Administration review for marketing approval |